28 related articles for article (PubMed ID: 8765425)
1. Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
Gentzler RD; Villaruz LC; Rhee JC; Horton B; Mock J; Hanley M; Kim K; Rudek MA; Phelps MA; Carducci MA; Piekarz R; Park KS; Bullock TN; Rudin CM
Oncologist; 2023 Nov; 28(11):1007-e1107. PubMed ID: 37555284
[TBL] [Abstract][Full Text] [Related]
2. Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D).
Sasaki Y; Fukuda M; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Yamada K; Kojima A; Nakagawa K
Jpn J Cancer Res; 1990 Feb; 81(2):196-200. PubMed ID: 2110134
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
Rinehart J; Margolin KA; Triozzi P; Hersh E; Campion M; Resta D; Levitt D
Clin Cancer Res; 1995 Oct; 1(10):1139-44. PubMed ID: 9815905
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.
Postmus PE; Gietema JA; Damsma O; Biesma B; Limburg PC; Vellenga E; de Vries EG
J Clin Oncol; 1992 Jul; 10(7):1131-40. PubMed ID: 1318953
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.
Veldhuis GJ; Willemse PH; van Gameren MM; Aalders JG; Mulder NH; Mull B; Biesma B; de Vries EG
J Clin Oncol; 1995 Mar; 13(3):733-40. PubMed ID: 7884433
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.
D'Hondt V; Weynants P; Humblet Y; Guillaume T; Canon JL; Beauduin M; Duprez P; Longueville J; Müll R; Chatelain C
J Clin Oncol; 1993 Nov; 11(11):2063-71. PubMed ID: 8229120
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.
Rinehart J; Hersh E; Issell B; Triozzi P; Buhles W; Neidhart J
Cancer Invest; 1997; 15(5):403-10. PubMed ID: 9316621
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study.
Kudoh S; Sawa T; Kurihara N; Furuse K; Kurita Y; Fukuoka M; Takada M; Takaku F; Ogawa M; Ariyoshi Y
Cancer Chemother Pharmacol; 1996; 38 Suppl():S89-95. PubMed ID: 8765425
[TBL] [Abstract][Full Text] [Related]
9. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Crawford J; George M
Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
[TBL] [Abstract][Full Text] [Related]
10. [Cytokine in cancer chemotherapy--clinical trials of IL-3, IL-11 and thrombopoietin against thrombocytopenia].
Kudoh S; Yamada M
Gan To Kagaku Ryoho; 1998 Jan; 25(2):171-6. PubMed ID: 9474925
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin and etoposide combined with radiotherapy for limited-stage small-cell esophageal carcinoma: three cases and review of the literature.
Isoyama Y; Shioyama Y; Nomoto S; Ohga S; Nonoshita T; Onishi K; Matsuura S; Atsumi K; Terashima K; Hirata H; Honda H
Jpn J Radiol; 2010 Apr; 28(3):181-7. PubMed ID: 20437127
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of recombinant human interleukin-3.
Ganser A; Lindemann A; Seipelt G; Ottmann OG; Herrmann F; Eder M; Frisch J; Schulz G; Mertelsmann R; Hoelzer D
Am J Clin Oncol; 1991; 14 Suppl 1():S51-63. PubMed ID: 2048566
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
